CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism

Journal of Allergy and Clinical Immunology

Volumn 123, Issue 6, 2009, Pages

  Ring, Sabine ^a   Oliver, Stephen J ^b   Cronstein, Bruce N ^b   Enk, Alexander H ^a   Mahnke, Karsten ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

adenosine; Contact hypersensitivity; endothelial cells; regulatory T cells; skinfold chamber

Indexed keywords

ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; APYRASE; CD4 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA; LEUKOCYTE ANTIGEN; PADGEM PROTEIN;

ANIMAL CELL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL CULTURE; CELL INTERACTION; CONTACT ALLERGY; CONTROLLED STUDY; EAR; EDEMA; ENDOTHELIUM CELL; FLOW CYTOMETRY; HYPERSENSITIVITY REACTION; LEUKOCYTE ADHERENCE; LYMPHOCYTE PROLIFERATION; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SHEAR STRESS; T LYMPHOCYTE SUBPOPULATION; VASCULAR ENDOTHELIUM; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL COMMUNICATION; CELL PROLIFERATION; CONTACT DERMATITIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ADENOSINE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; APYRASE; CELL COMMUNICATION; CELL PROLIFERATION; DERMATITIS, CONTACT; E-SELECTIN; ENDOTHELIAL CELLS; IMMUNE TOLERANCE; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; P-SELECTIN; T-LYMPHOCYTES, REGULATORY;

EID: 67649197277     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.03.022     Document Type: Article

References (44)

1. Vignali D.A., Collison L.W., and Workman C.J. How regulatory T cells work. Nat Rev Immunol 8 (2008) 523-532
2. Thornton A.M., and Shevach E.M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 164 (2000) 183-190
3. Nakamura K., Kitani A., Fuss I., et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol 172 (2004) 834-842
4. Asseman C., Mauze S., Leach M.W., Coffman R.L., and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190 (1999) 995-1004
5. Powrie F., Carlino J., Leach M.W., Mauze S., and Coffman R.L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 183 (1996) 2669-2674
6. Read S., Malmstrom V., and Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192 (2000) 295-302
7. Collison L.W., Workman C.J., Kuo T.T., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450 (2007) 566-569
8. Ring S., Thome M., Pretsch L., Enk A.H., and Mahnke K. Expanded murine regulatory T cells: analysis of phenotype and function in contact hypersensitivity reactions. J Immunol Methods 326 (2007) 10-21
9. Ring S., Schafer S.C., Mahnke K., Lehr H.A., and Enk A.H. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36 (2006) 2981-2992
10. Deaglio S., Dwyer K.M., Gao W., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204 (2007) 1257-1265
11. Enjyoji K., Sévigny J., Lin Y., et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5 (1999) 1010-1017
12. Tietz W., Allemand Y., Borges E., et al. CD4+ T cells migrate into inflamed skin only if they express ligands for E- and P-selectin. J Immunol 161 (1998) 963-970
13. Inaba K., Inaba M., Romani N., et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 (1992) 1693-1702
14. Newby A.C. Adenosine and the concept of "retaliatory metabolites". Trends Biochem Sci 9 (1984) 42-44
15. Odashima M., Bamias G., Rivera-Nieves J., et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129 (2005) 26-33
16. Naganuma M., Wiznerowicz E.B., Lappas C.M., et al. Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis. J Immunol 177 (2006) 2765-2769
17. Nemeth Z.H., Bleich D., Csoka B., et al. Adenosine receptor activation ameliorates type 1 diabetes. FASEB J 21 (2007) 2379-2388
18. Nemeth Z.H., Lutz C.S., Csoka B., et al. Adenosine augments IL-10 production by macrophages through an A2B receptor-mediated posttranscriptional mechanism. J Immunol 175 (2005) 8260-8270
19. Lappas C.M., Rieger J.M., and Linden J. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells. J Immunol 174 (2005) 1073-1080
20. Cronstein B.N. Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis. Pharmacol Rev 57 (2005) 163-172
21. Montesinos M.C., Takedachi M., Thompson L.F., et al. The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5′-nucleotidase: findings in a study of ecto-5′-nucleotidase gene-deficient mice. Arthritis Rheum 56 (2007) 1440-1445
22. Ohta A., Gorelik E., Prasad S.J., et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 103 (2006) 13132-13137
23. Pastor-Anglada M., Casado F.J., Valdes R., et al. Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Membr Biol 18 (2001) 81-85
24. Borsellino G., Kleinewietfeld M., Di M.D., et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110 (2007) 1225-1232
25. Rubtsov Y.P., Rasmussen J.P., Chi E.Y., et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28 (2008) 546-558
26. Jankovic D., Kullberg M.C., Feng C.G., et al. Conventional T-bet(+)Foxp3(-) Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J Exp Med 204 (2007) 273-283
27. Anderson C.F., Oukka M., Kuchroo V.J., and Sacks D. CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204 (2007) 285-297
28. Bours M.J., Swennen E.L., Di V.F., Cronstein B.N., and Dagnelie P.C. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112 (2006) 358-404
29. Imai M., Goepfert C., Kaczmarek E., and Robson S.C. CD39 modulates IL-1 release from activated endothelial cells. Biochem Biophys Res Commun 270 (2000) 272-278
30. Idzko M., Hammad H., van Nimwegen M., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13 (2007) 913-919
31. Mizumoto N., Kumamoto T., Robson S.C., et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8 (2002) 358-365
32. Mizumoto N., Mummert M.E., Shalhevet D., and Takashima A. Keratinocyte ATP release assay for testing skin-irritating potentials of structurally diverse chemicals. J Invest Dermatol 121 (2003) 1066-1072
33. Lennon P.F., Taylor C.T., Stahl G.L., and Colgan S.P. Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J Exp Med 188 (1998) 1433-1443
34. Eltzschig H.K., Faigle M., Knapp S., et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108 (2006) 1602-1610
35. Bouma M.G., van den Wildenberg F.A., and Buurman W.A. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol Cell Physiol 270 (1996) C522-C529
36. Cronstein B.N., Levin R.I., Philips M., et al. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148 (1992) 2201-2206
37. Sullivan G.W., Lee D.D., Ross W.G., et al. Activation of A2A adenosine receptors inhibits expression of alpha 4/beta 1 integrin (very late antigen-4) on stimulated human neutrophils. J Leukoc Biol 75 (2004) 127-134
38. Mostafa M.E., Chollet-Martin S., Oudghiri M., et al. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc Res 49 (2001) 882-890
39. Lisinski T.J., and Furie M.B. Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1 beta or tumor necrosis factor alpha. J Leukoc Biol 72 (2002) 503-511
40. Koszalka P., Ozuyaman B., Huo Y., et al. Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res 95 (2004) 814-821
41. Denning T.L., Kim G., and Kronenberg M. CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis. J Immunol 174 (2005) 7487-7491
42. Ochando J.C., Yopp A.C., Yang Y., et al. Lymph node occupancy is required for the peripheral development of alloantigen-specific Foxp3+ regulatory T cells. J Immunol 174 (2005) 6993-7005
43. Siewert C., Menning A., Dudda J., et al. Induction of organ-selective CD4+ regulatory T cell homing. Eur J Immunol 37 (2007) 978-989
44. Dudda J.C., Perdue N., Bachtanian E., and Campell D.J. FoxP3+ regulatory T cells maintain immune homeostasis in the skin. J Exp Med 205 (2008) 1559-1565